Pregestational Diabetes
15
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
13%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (15)
Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes
IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes
Automated Insulin for Management of Intrapartum Glycemia
CGM Accuracy in Pregnancy Study
Glucose Control in Type 2 Diabetes in Pregnancy
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
Permissive Intrapartum Glucose Control
the Efficacy of Fetal Arterial and Venous Doppler Indices in Predicting Perinatal Outcome
Maternal Diabetes in Newborns With Hearing Loss
Smartphone Utilization for Glucose Monitoring and Antenatal Reporting
Safety of Metformin in Pregnancy
Possible Epigenetic Changes in Offspring of Women With Pregestational and Gestational Diabetes
Intrapartum Maternal Glycemic Control Using Insulin Pump Versus Insulin Drip - Cohort Observational Trial